Immunologic Profile of Peritoneal Cancer
NCT03230240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-09-23
Summary
To ascertain immunologic profile of peritoneal cavity and its relationship to immediate postsurgical outcome (morbidity or the treatment) and long-term outcome (time to recurrence and survival).
Conditions
- Carcinomatosis
Interventions
- DRUG
-
HIPEC
heated intraIP chemotherapy
Sponsors & Collaborators
-
MercyOne Des Moines Medical Center
lead OTHER
Principal Investigators
-
Jan Franko, MD, PhD · MercyOne Des Moines Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2020-10-31
- Completion
- 2020-10-31
Countries
- United States
Study Locations
More Related Trials
-
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
NCT02249013 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
NCT00868192 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
NCT00230542 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
NCT00093496 ·Status: COMPLETED ·Phase: PHASE2
-
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
NCT03949283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00288275 ·Status: TERMINATED
-
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02839707 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
NCT04135521 ·Status: COMPLETED
-
Intra-peritoneal Chemotherapy in Ovarian Cancer
NCT02861872 ·Status: UNKNOWN
-
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
NCT00047632 ·Status: TERMINATED ·Phase: PHASE3
-
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
NCT04847063 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
NCT01579812 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02627443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
NCT02432378 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies
NCT03663712 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer
NCT00719212 ·Status: COMPLETED ·Phase: PHASE2
-
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
NCT03508570 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
NCT07219238 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NCT06611072 ·Status: RECRUITING ·Phase: NA
-
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
NCT01538498 ·Status: COMPLETED
-
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
NCT04213794 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
NCT00501644 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
NCT05256225 ·Status: RECRUITING ·Phase: PHASE3
-
Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer
NCT01637532 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
NCT00582205 ·Status: TERMINATED ·Phase: PHASE2